Results 211 to 220 of about 917,012 (395)

Ergotamine-induced venous thrombosis

, 1974
Uri Mintz, Simon Bar–Meir, André de Vries   +2 more
openalex   +1 more source

Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia

Proceedings of the National Academy of Sciences of the United States of America, 2017
N. Gupta, A. Sahu, A. Prabhakar, T. Chatterjee, Tarun Tyagi, B. Kumari, Nilofar Khan, V. Nair, N. Bajaj, M. Sharma, M. Ashraf   +10 more
semanticscholar   +1 more source

Radiotherapy-the not-so-insignificant contributor to cancer-associated venous thrombosis. [PDF]

Res Pract Thromb Haemost
Gurumurthy G, Miller J, Carrier M, Khorana A, Thachil J.   +4 more
europepmc   +1 more source

Intracranial venous thrombosis in young women.

, 1979
Bruno Estañol, Andrea Saénz de Miera Rodríguez, G Conte, José Abellán Alemán, M Loyo, J Pizzuto   +5 more
openalex   +1 more source

Detection of deep venous thrombosis by 99mTc-labelled red-cell scans. [PDF]

, 1979
Divina D’Auria
openalex   +1 more source

Cancer-associated pathways and biomarkers of venous thrombosis.

Blood, 2017
Y. Hisada, N. Mackman
semanticscholar   +1 more source

Venous thrombosis unchained: Pandora's box of noninflammatory mechanisms. [PDF]

Blood Adv
Smith SRM, Morgan NV, Brill A.
europepmc   +1 more source

Fibrinopeptide A (FPA) Levels in Venous Thrombosis and Pulmonary Embolism Before and During Anticoagulant Therapy [PDF]

, 1977
I. Yudelman, H. L. Nossel, KL Kaplan, J. Hirsh   +3 more
openalex   +1 more source

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

Stroke, 2011
G. Saposnik, F. Barinagarrementería, Robert D. Brown, C. Bushnell, B. Cucchiara, M. Cushman, G. deVeber, J. Ferro, Fong Y. Tsai   +8 more
semanticscholar   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu, Qiuhong Zhang, Jie Gao, Shiyuan Yao, Chan Tian, Tuo He, Ming Zhang, Hu Shan, Jie Shi, Bo Yuan, Lei Wang, Xia Yang   +11 more
wiley   +1 more source